Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 3
2015 2
2016 3
2017 1
2018 1
2019 3
2020 8
2021 6
2022 12
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
[Salivary gland carcinoma].
Lassche G, van Engen-van Grunsven ACH, Honings J, Dijkema T, Weijs WLJ, van Herpen CML. Lassche G, et al. Among authors: van engen van grunsven ach. Ned Tijdschr Geneeskd. 2020 Jul 16;164:D4760. Ned Tijdschr Geneeskd. 2020. PMID: 32779918 Dutch.
Advances and challenges in precision medicine in salivary gland cancer.
Lassche G, van Boxtel W, Ligtenberg MJL, van Engen-van Grunsven ACH, van Herpen CML. Lassche G, et al. Among authors: van engen van grunsven ach. Cancer Treat Rev. 2019 Nov;80:101906. doi: 10.1016/j.ctrv.2019.101906. Epub 2019 Oct 14. Cancer Treat Rev. 2019. PMID: 31644971 Review.
Cutaneous lymphangitis carcinomatosa in salivary duct carcinoma.
Uijen MJ, Weijers JA, Lassche G, van Ravensteijn SG, van Rijk MC, Lubeek SF, van Engen-van Grunsven AC, Amir A, Driessen CM, van Herpen CM. Uijen MJ, et al. Among authors: van engen van grunsven ac. J Clin Pathol. 2023 Mar;76(3):211-213. doi: 10.1136/jcp-2022-208564. Epub 2022 Nov 8. J Clin Pathol. 2023. PMID: 36347591 No abstract available.
IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer.
Crezee T, Tesselaar MH, Jaeger M, Rabold K, Corver WE, Morreau H, Van Engen-Van Grunsven ACH, Smit JWA, Netea-Maier RT, Plantinga TS. Crezee T, et al. Among authors: van engen van grunsven ach. Oncol Lett. 2021 Aug;22(2):590. doi: 10.3892/ol.2021.12851. Epub 2021 Jun 6. Oncol Lett. 2021. PMID: 34149901 Free PMC article.
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
de Koster EJ, de Geus-Oei LF, Brouwers AH, van Dam EWCM, Dijkhorst-Oei LT, van Engen-van Grunsven ACH, van den Hout WB, Klooker TK, Netea-Maier RT, Snel M, Oyen WJG, Vriens D; EfFECTS trial study group. de Koster EJ, et al. Among authors: van engen van grunsven ach. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1970-1984. doi: 10.1007/s00259-021-05627-2. Epub 2022 Jan 4. Eur J Nucl Med Mol Imaging. 2022. PMID: 34981165 Free PMC article. Clinical Trial.
Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol.
Driessen DAJJ, de Gouw DJJM, Stijns RCH, Litjens G, Israël B, Philips BWJ, Hermans JJ, Dijkema T, Klarenbeek BR, van der Post RS, Nagtegaal ID, van Engen-van Grunsven ACH, Brosens LAA, Veltien A, Zámecnik P, Scheenen TWJ. Driessen DAJJ, et al. Among authors: van engen van grunsven ach. Methods Protoc. 2022 Mar 7;5(2):24. doi: 10.3390/mps5020024. Methods Protoc. 2022. PMID: 35314661 Free PMC article.
40 results